141 related articles for article (PubMed ID: 6178872)
21. Converting enzyme inhibition and glomerular size selectivity in diabetic nephropathy.
Meyer TW; Morelli E; Loon N; Peters W; Myers BD
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S64-8. PubMed ID: 16989068
[TBL] [Abstract][Full Text] [Related]
22. Permselectivity in thin membrane nephropathy.
Thomas DM; Coles GA; Griffiths DF; Williams JD
J Clin Invest; 1994 May; 93(5):1881-4. PubMed ID: 7514188
[TBL] [Abstract][Full Text] [Related]
23. Effect of colloid volume expansion on glomerular barrier size-selectivity in humans.
Shemesh O; Deen WM; Brenner BM; McNeely E; Myers BD
Kidney Int; 1986 Apr; 29(4):916-23. PubMed ID: 3712975
[TBL] [Abstract][Full Text] [Related]
24. Glomerular proteinuria in renal transplant patients: mechanisms and treatment.
Barnas U; Mayer G
Kidney Int Suppl; 1997 Dec; 63():S78-80. PubMed ID: 9407428
[TBL] [Abstract][Full Text] [Related]
25. Reduction in mean glomerular pore size coincides with the development of large shunt pores in patients with diabetic nephropathy.
Oberbauer R; Nenov V; Weidekamm C; Haas M; Szekeres T; Mayer G
Exp Nephrol; 2001; 9(1):49-53. PubMed ID: 11053980
[TBL] [Abstract][Full Text] [Related]
26. Glomerular capillary wall function in human lupus nephritis.
Friedman S; Strober S; Field EH; Silverman E; Myers BD
Am J Physiol; 1984 May; 246(5 Pt 2):F580-91. PubMed ID: 6720964
[TBL] [Abstract][Full Text] [Related]
27. Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
Ruggenenti P; Mosconi L; Sangalli F; Casiraghi F; Gambara V; Remuzzi G; Remuzzi A
Kidney Int; 1999 Mar; 55(3):984-94. PubMed ID: 10027935
[TBL] [Abstract][Full Text] [Related]
28. Glomerular permeability to neutral and anionic dextrans in experimental diabetes.
Michels LD; Davidman M; Keane WF
Kidney Int; 1982 May; 21(5):699-705. PubMed ID: 6180213
[TBL] [Abstract][Full Text] [Related]
29. The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy.
Viberti G; Keen H
Diabetes; 1984 Jul; 33(7):686-92. PubMed ID: 6376224
[No Abstract] [Full Text] [Related]
30. The mechanisms of proteinuria in aging rats.
Baylis C; Fredericks M; Leypoldt J; Frigon R; Wilson C; Henderson L
Mech Ageing Dev; 1988 Nov; 45(2):111-26. PubMed ID: 2462659
[TBL] [Abstract][Full Text] [Related]
31. Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice.
Jeansson M; Granqvist AB; Nyström JS; Haraldsson B
Diabetologia; 2006 Sep; 49(9):2200-9. PubMed ID: 16868749
[TBL] [Abstract][Full Text] [Related]
32. Ultrastructural changes of the glomerular basement membrane in diabetic nephropathy revealed by newly devised tissue negative staining method.
Ota K; Ota Z; Shikata K; Makino H
Acta Med Okayama; 1993 Aug; 47(4):267-72. PubMed ID: 7692703
[TBL] [Abstract][Full Text] [Related]
33. Glomerular dysfunction in diabetic nephropathy.
Zucchelli P; Zuccalà A; Sturani A
Postgrad Med J; 1988; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295
[TBL] [Abstract][Full Text] [Related]
34. Changes in heparan sulfate correlate with increased glomerular permeability.
Groggel GC; Stevenson J; Hovingh P; Linker A; Border WA
Kidney Int; 1988 Feb; 33(2):517-23. PubMed ID: 2452273
[TBL] [Abstract][Full Text] [Related]
35. Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset.
Myers BD; Nelson RG; Williams GW; Bennett PH; Hardy SA; Berg RL; Loon N; Knowler WC; Mitch WE
J Clin Invest; 1991 Aug; 88(2):524-30. PubMed ID: 1864963
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans.
Golbetz H; Black V; Shemesh O; Myers BD
Am J Physiol; 1989 Jan; 256(1 Pt 2):F44-51. PubMed ID: 2463770
[TBL] [Abstract][Full Text] [Related]
37. Glomerular response to hyperglycemia in human diabetic nephropathy.
Remuzzi A; Viberti G; Ruggenenti P; Battaglia C; Pagni R; Remuzzi G
Am J Physiol; 1990 Oct; 259(4 Pt 2):F545-52. PubMed ID: 2221091
[TBL] [Abstract][Full Text] [Related]
38. Reduced glomerular size selectivity in late streptozotocin-induced diabetes in rats: application of a distributed two-pore model.
Lubbad L; Öberg CM; Dhanasekaran S; Nemmar A; Hammad F; Pathan JY; Rippe B; Bakoush O
Physiol Rep; 2015 May; 3(5):. PubMed ID: 26009635
[TBL] [Abstract][Full Text] [Related]
39. Diabetic nephropathy. A perspective.
Mauer SM; Steffes MW; Goetz FC; Sutherland DE; Brown DM
Diabetes; 1983 May; 32 Suppl 2():52-5. PubMed ID: 6400668
[TBL] [Abstract][Full Text] [Related]
40. Functional characteristics of the glomerular filter in the IgA-nephropathy.
Langhorne P; Whiting PH; Petersen J; Ireland A; Ross IS; Velasco N; Catto GR; Edward N; Simpson JG
Int J Microcirc Clin Exp; 1985; 4(2):131-9. PubMed ID: 2412982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
